BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 25, 2006
View Archived Issues
Lorus Therapeutics: Q2 review
Read More
Phase IIb draft protocol submitted for CF-101 in rheumatoid arthritis
Read More
Enrollment open in phase Ib study of PX-12 for advanced gastrointestinal cancers
Read More
Independent confirmations of NeuGene efficacy against influenza strains
Read More
Inspire discontinues development of denufosol tetrasodium for retinal diseases
Read More
Biovitrum and Syntonix sign agreement for long-acting recombinant Factor IX
Read More
CytRx plans open-label extension to phase II ALS study of arimoclomol
Read More
Spectrum to benefit from satraplatin license agreement
Read More
Cloretazine receives European orphan drug designation for AML
Read More
Tosufloxacin tosilate ophthalmic solution approved in Japan
Read More
Dyloject relieves postoperative pain faster than ketorolac in phase IIb study
Read More
Advisory Committee sets date for Cubicin sNDA review
Read More
FDA Advisory Committee recommends OTC approval of orlistat 60 mg
Read More
Phase IIb study of obesity drug AOD-9604 proceeds on schedule
Read More
Attenuated human rotavirus vaccine effective against severe gastroenteritis
Read More
Antitumor activity of SU-11248 evaluated in phase I and II trials
Read More
Studies indicate GR-270773 can be used with levofloxacin and propofol
Read More
MP-4 safe, reduces hypotensive episodes in orthopedic surgery patients
Read More
Antisense technology protects 75% of monkeys against Ebola
Read More
Stat3 as a target for inducing antitumor immune response
Read More
Recent patents cover therapeutic agents for neurological disorders
Read More
Recent Taisho and Rib-X patents describe novel antiinfective agents
Read More
Therapeutic agents for hepatitis C infection jointly claimed by Merck and Isis
Read More
European approval for Cubicin in complicated skin and soft-tissue infections
Read More